- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01259427
Reducing Internalized Stigma in People With Serious Mental Illness (ESS)
Reducing Internalized Stigma In People With Serious Mental Illness
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Stigmatizing beliefs and attitudes about mental illness are prevalent and exposure to stigma is common among people with mental illness. The negative effects of stigma are compounded when a veteran with Serious Mental Illness (SMI) internalizes these stigmatizing assumptions and stereotypes. Internalized stigma refers to the process in which a person with mental illness cognitively or emotionally absorbs negative messages or stereotypes about mental illness and comes to believe them and apply them to him/herself. Internalized stigma is evident among veterans with SMI and can lead to decreased self-efficacy, increased depression, social withdrawal, and curtailed pursuit of recovery goals.
Objectives:
The investigators developed Ending Self Stigma (ESS), a 9-session group intervention to assist veterans with SMI to develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes. The primary objectives of this project are to compare the effects of ESS to a general health and wellness group in: 1) reducing internalized stigma and 2) improving proximal psychosocial outcomes (e.g., self-efficacy, belonging, recovery orientation). Secondary objectives include assessing the effects of ESS on improving distal psychosocial outcomes (e.g., quality of life, social functioning) and examining if improvements are maintained 6-months post-treatment.
Methods:
This study is a randomized trial of veterans with SMI receiving outpatient mental health services from three VA Medical Centers. Participants are randomly assigned to ESS or a general health and wellness group, which they attend once a week for 9 weeks. ESS focuses on teaching strategies/tools to help participants address self-stigma. The health and wellness group focuses on providing information/ education to help participants better manage health-related concerns (e.g. physical activity, nutrition). Participants complete assessments at baseline, post-treatment, and 6-months post-treatment. A two-level mixed effects model with adjustment for baseline response will be used to address the primary and secondary aims. Qualitative data on veterans' experiences of and strategies for coping with internalized stigma are being collected from a subset of veterans from both conditions to compare experiences of veterans in both groups and explore any reasons for ESS drop-out.
Status:
Data collection for the project is completed. Analysis of 6-month post-treatment assessments and qualitative interviews are currently being conducted.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20422
- Washington DC VA Medical Center, Washington, DC
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- VA Maryland Health Care System, Baltimore
-
Perry Point, Maryland, United States, 21902
- Perry Point VA Medical Center VA Maryland Health Care System, Perry Point, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of Schizophrenia
- Schizoaffective disorder
- Bipolar Disorder
- or Major Depression with Psychotic Features
- Age 18 to 80
- Receiving services at one of VA Medical Center study sites
- Ability and willingness to provide consent to participate
- Agreement obtained from the treating clinician that the patient is clinically stable enough to participate in the study
Exclusion Criteria:
- Severe or profound mental retardation by chart review
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm 1: Ending Self Stigma
Ending Self Stigma (ESS): Ending Self Stigma (ESS) is a 9-session small-group (4-8 persons) course designed to help individuals with serious mental Illness (SMI) develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes.
Sessions combine in-class lecture, discussion of relevance to group members' personal experiences, review and practice of strategies and skills, and group sharing, support, and problem-solving.
Each session is designed to focus on a specific strategy for addressing self-stigma.
|
Ending Self Stigma (ESS) is a 9-session small-group (4-8 persons) course designed to help individuals with serious mental Illness (SMI) develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes.
Sessions combine in-class lecture, discussion of relevance to group members' personal experiences, review and practice of strategies and skills, and group sharing, support, and problem-solving.
Each session is designed to focus on a specific strategy for addressing self-stigma.
|
|
Active Comparator: Arm 2: Health and Wellness Group
Health and Wellness Group: The Health and Wellness group is a 9-session small-group (4-8 persons) course designed for individuals with serious mental illness (SMI).
Each session focuses on discussion of specific health and wellness related issues and education on ways to better manage health related concerns (e.g., physical activity/exercise, nutrition, managing fatigue/sleep, tobacco and other substance use, etc).
|
The Health and Wellness group is a 9-session small-group (4-8 persons) course designed for individuals with serious mental illness (SMI).
Each session focuses on discussion of specific health and wellness related issues and education on ways to better manage health related concerns (e.g., physical activity/exercise, nutrition, managing fatigue/sleep, tobacco and other substance use, etc).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internalized Stigma of Mental Illness Inventory (Internalized Stigma)
Time Frame: ~3 months (post-treatment)
|
The Internalized Stigma of Mental Illness Inventory was used to measure of internalized or self-stigma.
A total score is calculated by taking an average of the responses on the items (range=1 to 4).
Higher total scores indicate greater internalized stigma.
|
~3 months (post-treatment)
|
|
Maryland Assessment of Recovery for Serious Mental Illness Scale (Recovery)
Time Frame: ~3 1/2 months (post-treatment)
|
The Maryland Assessment of Recovery in Serious Mental Illness is a self-report measure of recovery in people with serious mental illness.
A total score was calculated by summing item responses (range=25 to 125), with higher total scores indicating greater self-reported recovery.
|
~3 1/2 months (post-treatment)
|
|
General Self-Efficacy Scale
Time Frame: ~3 1/2 months (post-treatment)
|
The General Self-efficacy measure was used to measure of self-efficacy.
A total score was calculated by averaging the responses on the items (range=1 to 5), with higher scores indicating greater self-efficacy.
|
~3 1/2 months (post-treatment)
|
|
Sense of Belonging Instrument (Belonging)
Time Frame: ~3 1/2 months (post-treatment)
|
The Sense of Belonging Instrument was used to measure perceived belongingness.
The measure includes two subscales: the psychological experience of belonging (SOBI-P) and antecedents that foster belonging (SOBI-A).
An average of the sum of the items in each subscale were used to calculate the total score for that subscale.
The total score of the SOBI-P ranges from 18 to 72, with higher scores indicating less experienced belonging.
The total score of the SOBI-A ranges from 14-56 with higher score indicating greater antecedents that foster belonging.
|
~3 1/2 months (post-treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life
Time Frame: ~3 1/2 months (post-treatment)
|
The Satisfaction with Life in General item from the Brief Quality of Life Scale was used to assess self-reported life satisfaction.
The item is rated on a 7-point scale that ranges from terrible to delighted (range=1 to 7), with greater scores indicating more satisfaction.
|
~3 1/2 months (post-treatment)
|
|
Social Engagement/Withdrawal
Time Frame: ~3 1/2 months (post-treatment)
|
The total score of the Social Engagement/Withdrawal subscale of the Social Functioning Scale was used to measure social engagement.
The total score ranges from 0 to 15 with higher scores indicating greater social engagement.
|
~3 1/2 months (post-treatment)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Amy L Drapalski, PhD, VA Maryland Health Care System, Baltimore
Publications and helpful links
General Publications
- Yanos PT, Lucksted A, Drapalski AL, Roe D, Lysaker P. Interventions targeting mental health self-stigma: A review and comparison. Psychiatr Rehabil J. 2015 Jun;38(2):171-178. doi: 10.1037/prj0000100. Epub 2014 Oct 13.
- Drapalski AL, Lucksted A, Brown CH, Fang LJ. Outcomes of Ending Self-Stigma, a Group Intervention to Reduce Internalized Stigma, Among Individuals With Serious Mental Illness. Psychiatr Serv. 2021 Feb 1;72(2):136-142. doi: 10.1176/appi.ps.201900296. Epub 2020 Nov 25.
- Wastler H, Lucksted A, Phalen P, Drapalski A. Internalized stigma, sense of belonging, and suicidal ideation among veterans with serious mental illness. Psychiatr Rehabil J. 2020 Jun;43(2):91-96. doi: 10.1037/prj0000386. Epub 2019 Aug 15.
- Jahn DR, Leith J, Muralidharan A, Brown CH, Drapalski AL, Hack S, Lucksted A. The influence of experiences of stigma on recovery: Mediating roles of internalized stigma, self-esteem, and self-efficacy. Psychiatr Rehabil J. 2020 Jun;43(2):97-105. doi: 10.1037/prj0000377. Epub 2019 Jun 24.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIR 09-340
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Recruiting
-
Bradley LegaRecruiting
Clinical Trials on Ending Self Stigma (ESS)
-
VA Office of Research and DevelopmentCompleted
-
University Hospital, Strasbourg, FranceRecruitingDepression | Schizophrenia | Bipolar Disorder | Autism Spectrum Disorder | Borderline Personality DisorderFrance
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA); Johns Hopkins University; University...Active, not recruitingHIV | Substance Use | Stigma, SocialUnited States
-
Florida State UniversityFogarty International Center of the National Institute of HealthCompleted
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH); Institute of HIV Research and Innovation...Recruiting
-
East Tennessee State UniversityCompletedBehavior | Stigma, SocialUnited States
-
Queen's UniversityActive, not recruitingSchizophrenia | PsychosisCanada
-
Ege UniversityCompletedCBT | Gambling Disorder | Cognitive Behavioral Therapy | Stigma | Stigma of Mental Illness | Gambling Addiction | Gambling Disorder Treatment | Self StigmaTurkey (Türkiye)
-
University of ChileMinistry of Health, ChileCompletedSchizophrenia | Schizoaffective Disorder | Bipolar DisorderChile
-
University of ConnecticutMedical Research Council, South AfricaActive, not recruitingHIV I InfectionUnited States